330 related articles for article (PubMed ID: 10511592)
1. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
[TBL] [Abstract][Full Text] [Related]
2. Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
Kitazono M; Okumura H; Ikeda R; Sumizawa T; Furukawa T; Nagayama S; Seto K; Aikou T; Akiyama S
Int J Cancer; 2001 Jan; 91(1):126-31. PubMed ID: 11149411
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms for resistance to anticancer agents and the reversal of the resistance].
Akiyama S; Chen ZS; Kitazono M; Sumizawa T; Furukawa T; Aikou T
Hum Cell; 1999 Sep; 12(3):95-102. PubMed ID: 10695015
[TBL] [Abstract][Full Text] [Related]
4. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
5. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Stein U; Walther W; Laurencot CM; Scheffer GL; Scheper RJ; Shoemaker RH
J Natl Cancer Inst; 1997 Jun; 89(11):807-13. PubMed ID: 9182980
[TBL] [Abstract][Full Text] [Related]
8. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
9. Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution.
Cheng SH; Lam W; Lee AS; Fung KP; Wu RS; Fong WF
Toxicol Appl Pharmacol; 2000 Apr; 164(2):134-42. PubMed ID: 10764626
[TBL] [Abstract][Full Text] [Related]
10. [Sodium butyrate-induced expression of lung resistance-related gene in human myeloid leukemia K562 cells].
Li N; Qian XH; Yao YM; Wang ZY
Ai Zheng; 2003 Aug; 22(8):821-5. PubMed ID: 12917027
[TBL] [Abstract][Full Text] [Related]
11. Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.
Meschini S; Marra M; Calcabrini A; Monti E; Gariboldi M; Dolfini E; Arancia G
Toxicol In Vitro; 2002 Aug; 16(4):389-98. PubMed ID: 12110277
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-based assessment of LRP activity: a comparative study.
Durdux M; Grunwald D; Gautier T; Ronot X; Boutonnat J
Anticancer Res; 2004; 24(2B):725-32. PubMed ID: 15161018
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart.
Reinecke P; Steckstor M; Schmitz M; Gabbert HE; Gerharz CD
Oncol Rep; 2004 Mar; 11(3):641-5. PubMed ID: 14767515
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
Uchiyama-Kokubu N; Watanabe T
Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.
Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M
Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450
[TBL] [Abstract][Full Text] [Related]
17. Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
Kusakabe H; Iwasaki H; Sano K; Kiyokane K
Arch Dermatol Res; 2000 Jun; 292(6):292-300. PubMed ID: 10929770
[TBL] [Abstract][Full Text] [Related]
18. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
20. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]